Thread: Phytopharm: Commencement of Clinical Study of Cogane in Patients with PD
View Single Post
Old 04-20-2009, 09:21 AM
Stitcher's Avatar
Stitcher Stitcher is offline
Magnate
  
Join Date: Aug 2006
Posts: 2,136
15 yr Member
Stitcher Stitcher is offline
Magnate
Stitcher's Avatar
 
Join Date: Aug 2006
Posts: 2,136
15 yr Member
Default Phytopharm: Commencement of Clinical Study of Cogane in Patients with PD
Phytopharm: Commencement of Clinical Study of Cogane in Patients with Parkinson's disease

http://www.pharmalive.com/News/index...&categoryid=21

GODMANCHESTER, Cambridgeshire, England, 20 April 2009, Phytopharm plc today announces the commencement of a safety, tolerability and pharmacokinetic (PK) study of its orally active neurotrophic factor inducer PYM50028 (Cogane•), which will involve both healthy volunteers and patients with Parkinson’s disease (PD). This follows approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) and Research Ethics Committee to commence recruitment for the UK study.
Stitcher is offline   Reply With QuoteReply With Quote